
Catch up on the latest imaging research presented at the recent American Society for Radiation Oncology (ASTRO) Annual Meeting.
MRI contrast agent developer Advanced Magnetics of Cambridge,MA, reported last week that it has received a $5 million milestonepayment from Berlex Laboratories due to Berlex's launch of FeridexIV, a liver-specific contrast agent developed by Advanced
MRI contrast agent developer Advanced Magnetics of Cambridge,
MA, reported last week that it has received a $5 million milestone
payment from Berlex Laboratories due to Berlex's launch of Feridex
IV, a liver-specific contrast agent developed by Advanced Magnetics
(SCAN 9/11/96).







